Cargando…
Targeted Cancer Therapy: What’s New in the Field of Neuroendocrine Neoplasms?
SIMPLE SUMMARY: Neuroendocrine neoplasms are highly heterogeneous tumors in terms of primary origin, molecular landscape, clinical presentation and behavior. To date, several drugs have been approved and many ongoing trials are testing new agents or new combinations. In this work we aim to provide a...
Autores principales: | La Salvia, Anna, Espinosa-Olarte, Paula, Riesco-Martinez, Maria Del Carmen, Anton-Pascual, Beatriz, Garcia-Carbonero, Rocío |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8038369/ https://www.ncbi.nlm.nih.gov/pubmed/33916707 http://dx.doi.org/10.3390/cancers13071701 |
Ejemplares similares
-
Chemotherapy in NEN: still has a role?
por: Espinosa-Olarte, Paula, et al.
Publicado: (2021) -
Correction to: Chemotherapy in NEN: still has a role?
por: Espinosa-Olarte, Paula, et al.
Publicado: (2022) -
MicroRNA signature and integrative omics analyses define prognostic clusters and key pathways driving prognosis in patients with neuroendocrine neoplasms
por: Soldevilla, Beatriz, et al.
Publicado: (2023) -
Advances in the Treatment of Gastroenteropancreatic Neuroendocrine Carcinomas: Are we Moving Forward?
por: Garcia-Carbonero, Rocio, et al.
Publicado: (2023) -
Comprehensive Plasma Metabolomic Profile of Patients with Advanced Neuroendocrine Tumors (NETs). Diagnostic and Biological Relevance
por: Soldevilla, Beatriz, et al.
Publicado: (2021)